Daily Stock Ratings & Price Targets
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Market Cap
Any
Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
|---|---|---|---|---|---|---|---|---|---|
 xxxxxxxxxxxxxxxxxx | BUY $411→$391 | ― | 2.20% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | HOLD $20→$23 | ― | 2.20% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | BUY $647→$645 | ― | 2.20% | Reiterated | |||||
 | Affirm Holdings | BUY $97→$105 | ― | -0.70% | Reiterated | Analysts Conflicted on These Financial Names: Affirm Holdings (NASDAQ: AFRM) and Toronto Dominion Bank (NYSE: TD) | |||
 xxxxxxxxxxxxxxxxxx | BUY $172 | ― | 10.20% | Reiterated | |||||
 xxxxxxxxxxxxxxxxxx | BUY $110→$115 | ― | 14.40% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | HOLD $22→$23 | ― | 14.40% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | BUY $200→$224 | ― | 10.20% | Reiterated | |||||
| Aveanna Healthcare Holdings | BUY $9.5→$15 | ― | -3.50% | Reiterated | Barclays Sticks to Its Buy Rating for Aveanna Healthcare Holdings (AVAH) | |||
| Radnet | BUY $65→$79 | ― | -3.50% | Reiterated | Barclays Sticks to Their Buy Rating for Radnet (RDNT) | |||
| Acadia Healthcare | HOLD $32 | ― | -3.50% | Reiterated | Barclays Remains a Hold on Acadia Healthcare (ACHC) | |||
| Addus Homecare | SELL $96 | ― | -3.50% | Reiterated | Barclays Reaffirms Their Sell Rating on Addus Homecare (ADUS) | |||
| Astrana Health | BUY $53 | ― | -3.50% | Reiterated | Barclays Sticks to Their Buy Rating for Astrana Health (ASTH) | |||
| GMR Solutions, Inc. Class A | BUY $16 | ― | -3.50% | Reiterated | GMR Solutions, Inc. Class A (GMRS) Gets a Buy from Barclays | |||
 xxxxxxxxxxxxxxxxxx | HOLD $110 | ― | 19.80% | Reiterated | |||||
 | Best Buy Co | HOLD $85 | ― | -6.40% | Reiterated | Barclays Reaffirms Their Hold Rating on Best Buy Co (BBY) | |||
| xxxxxxxxxxxxxxxxxx | HOLD $75 | ― | 19.80% | Reiterated | |||||
| Privia Health Group | HOLD $24 | ― | -3.50% | Reiterated | Barclays Reaffirms Their Hold Rating on Privia Health Group (PRVA) | |||
| xxxxxxxxxxxxxxxxxx | SELL $23 | ― | 19.80% | Reiterated | |||||
| Surgery Partners | HOLD $14 | ― | -3.50% | Reiterated | Barclays Remains a Hold on Surgery Partners (SGRY) | |||
| Lumexa Imaging Holdings, Inc. | BUY $13 | ― | -3.50% | Reiterated | Lumexa Imaging Holdings, Inc. (LMRI) Gets a Buy from Barclays | |||
| Malibu Boats | HOLD ― | ― | -4.10% | Reiterated | Wall Street Analysts Are Neutral on Top Consumer Cyclical Picks | |||
| xxxxxxxxxxxxxxxxxx | HOLD ― | ― | 45.90% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | BUY $112→$120 | ― | 27.50% | Reiterated | |||||
 xxxxxxxxxxxxxxxxxx | BUY $158→$215 | ― | 6.50% | Reiterated | |||||
 xxxxxxxxxxxxxxxxxx | BUY $25→$26 | ― | 19.70% | Reiterated | |||||
 xxxxxxxxxxxxxxxxxx | HOLD $100→$94 | ― | 2.40% | Reiterated | |||||
 xxxxxxxxxxxxxxxxxx | BUY ― | ― | 6.10% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | HOLD $5 | ― | 16.90% | Downgraded | |||||
| xxxxxxxxxxxxxxxxxx | BUY $300 | ― | 4.30% | Reiterated | |||||
 | Best Buy Co | HOLD $85 | ― | -0.60% | Assigned | Wall Street Analysts Are Neutral on Top Consumer Cyclical Picks | |||
| xxxxxxxxxxxxxxxxxx | HOLD $219 | ― | 21.10% | Downgraded | |||||
| xxxxxxxxxxxxxxxxxx | BUY $3.2→$3.8 | ― | 35.10% | Upgraded | |||||
 xxxxxxxxxxxxxxxxxx | BUY $300 | ― | 53.30% | Reiterated | |||||
 xxxxxxxxxxxxxxxxxx | HOLD $125 | ― | 10.90% | Reiterated | |||||
| CrowdStrike Holdings | BUY $230→$235 | ― | 0.10% | Reiterated | New Buy Rating for CrowdStrike Holdings (CRWD), the Technology Giant | |||
| Workday | BUY $215→$225 | ― | 0.10% | Assigned | Workday (WDAY): New Buy Recommendation for This Technology Giant | |||
 xxxxxxxxxxxxxxxxxx | HOLD ― | ― | 55.10% | Reiterated | |||||
| Ulta Beauty | HOLD $560→$580 | ― | 0.20% | Reiterated | Ulta Beauty price target raised to $580 from $560 at Citi | |||
| xxxxxxxxxxxxxxxxxx | BUY $23→$25 | ― | 31.30% | Reiterated | |||||
 xxxxxxxxxxxxxxxxxx | HOLD $17→$23 | ― | 23.80% | Reiterated | |||||
 | Workday | HOLD $139→$201 | ― | -0.70% | Reiterated | Workday price target raised to $201 from $139 at Citi | |||
| xxxxxxxxxxxxxxxxxx | BUY $22 | ― | 26.10% | Reiterated | |||||
 | Healthequity | BUY $115 | ― | -3.80% | Reiterated | Analysts Have Conflicting Sentiments on These Healthcare Companies: Healthequity (NASDAQ: HQY) and Ramsay Health Care (Other OTC: RMSYF) | |||
 xxxxxxxxxxxxxxxxxx | BUY $26→$27 | ― | 4.70% | Assigned | |||||
 xxxxxxxxxxxxxxxxxx | BUY $109→$125 | ― | 15.50% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | HOLD $172→$182 | ― | 12.70% | Reiterated | |||||
 xxxxxxxxxxxxxxxxxx | HOLD $27 | ― | 7.10% | Reiterated | |||||
 xxxxxxxxxxxxxxxxxx | BUY $115 | ― | 6.90% | Reiterated | |||||
 xxxxxxxxxxxxxxxxxx | BUY $80 | ― | 28.10% | Reiterated |
Rows:
